• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医药灌肠疗法治疗1例呼吸道新型冠状病毒核酸检测阴性但肠道核酸检测阳性患者:病例报告

Traditional Chinese Medicine Enema Therapy in a Patient With a Confirmed Negative SARS-CoV-2 Test in the Respiratory Tract but Positive in the Intestinal Tract: A Case Report.

作者信息

Dai Yuzhu, Zhao Zhiyou, Zhou Huajun, Huang Dedong, Luo Jianjun, Zhang Cunhai, Chen Qingyong, Chen Xingcan, Yao Yuan, Jiang Xiaoxiao, Cheng Jun

机构信息

Department of Clinical Laboratory, West Lake Hospital Affiliated to Hangzhou Medical College, Hangzhou, China.

Department of Traditional Chinese Medicine, West Lake Hospital Affiliated to Hangzhou Medical College, Hangzhou, China.

出版信息

Front Public Health. 2021 Jul 9;9:687283. doi: 10.3389/fpubh.2021.687283. eCollection 2021.

DOI:10.3389/fpubh.2021.687283
PMID:34307281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8299274/
Abstract

We report the case of a 43-year-old man who was infected with SARS-CoV-2 in February 2020 and actively cooperated with treatment in the hospital. During the course of treatment, we found that the respiratory SARS-CoV-2 nucleic acid became negative, but remained positive in the intestinal tract. As a result, we adjusted the treatment plan to include traditional Chinese medicine enema treatment. The patient had negative intestinal SARS-CoV-2 nucleic acid test within 4 days, and the subsequent repeated review of intestinal SARS-CoV-2 nucleic acid was negative, and the virus was undetectable. It is suggested that traditional Chinese medicine enema treatment may be helpful to remove the SARS-CoV-2 in the intestines of patients with COVID-19 infection, and may support the treatment of patients with respiratory SARS-CoV-2 nucleic acid negative and positive in the intestinal tract.

摘要

我们报告了一名43岁男性的病例,该患者于2020年2月感染了SARS-CoV-2,并在医院积极配合治疗。在治疗过程中,我们发现呼吸道SARS-CoV-2核酸转为阴性,但肠道内仍为阳性。因此,我们调整了治疗方案,加入了中药灌肠治疗。患者在4天内肠道SARS-CoV-2核酸检测呈阴性,随后多次复查肠道SARS-CoV-2核酸均为阴性,病毒检测不到。提示中药灌肠治疗可能有助于清除COVID-19感染患者肠道内的SARS-CoV-2,并可能对呼吸道SARS-CoV-2核酸阴性而肠道内阳性的患者治疗有辅助作用。

相似文献

1
Traditional Chinese Medicine Enema Therapy in a Patient With a Confirmed Negative SARS-CoV-2 Test in the Respiratory Tract but Positive in the Intestinal Tract: A Case Report.中医药灌肠疗法治疗1例呼吸道新型冠状病毒核酸检测阴性但肠道核酸检测阳性患者:病例报告
Front Public Health. 2021 Jul 9;9:687283. doi: 10.3389/fpubh.2021.687283. eCollection 2021.
2
Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.中药麻杏石甘-苇茎汤治疗新型冠状病毒肺炎重型急性呼吸综合征患者的疗效:一项随机对照试验研究方案的结构化总结
Trials. 2020 Dec 23;21(1):1029. doi: 10.1186/s13063-020-04970-3.
3
The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.新型冠状病毒病患者核酸检测由阴转阳的机制及临床转归和法匹拉韦的疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):488. doi: 10.1186/s13063-020-04430-y.
4
Fecal-oral transmission of SARS-CoV-2: review of laboratory-confirmed virus in gastrointestinal system.SARS-CoV-2 的粪-口传播:胃肠道系统中实验室确认病毒的综述。
Int J Colorectal Dis. 2021 Mar;36(3):437-444. doi: 10.1007/s00384-020-03785-7. Epub 2020 Oct 14.
5
[Expert consensus on traditional Chinese medicine health management in adults with SARS-CoV-2 variant infection at home].[新型冠状病毒变异株感染成人居家中医药健康管理专家共识]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Dec;34(12):1233-1237. doi: 10.3760/cma.j.cn121430-20221210-01079.
6
The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.中药配方联合西药治疗 COVID-19 危重症病例。
Complement Ther Med. 2020 Aug;52:102473. doi: 10.1016/j.ctim.2020.102473. Epub 2020 Jun 9.
7
Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.热毒宁注射液治疗 COVID-19 的疗效和安全性及其对 SARS-CoV-2 的抑制作用。
J Ethnopharmacol. 2021 Oct 28;279:114367. doi: 10.1016/j.jep.2021.114367. Epub 2021 Jun 24.
8
Direct Evidence of Active SARS-CoV-2 Replication in the Intestine.肠道中活跃的 SARS-CoV-2 复制的直接证据。
Clin Infect Dis. 2021 Aug 2;73(3):361-366. doi: 10.1093/cid/ciaa925.
9
Persistent SARS-COV-2 RNA positivity in a patient for 92 days after disease onset: A case report.一名患者在疾病发作后92天内SARS-CoV-2 RNA持续呈阳性:病例报告。
Medicine (Baltimore). 2020 Aug 21;99(34):e21865. doi: 10.1097/MD.0000000000021865.
10
Impact of Paxlovid on in-hospital outcomes and post-COVID-19 condition in adult patients infected with SARS-CoV-2 Omicron variant: A non-randomized controlled clinical trial.帕罗韦德对感染 SARS-CoV-2 奥密克戎变异株的成年患者住院结局和新冠后状况的影响:一项非随机对照临床试验。
Medicine (Baltimore). 2023 Dec 22;102(51):e36714. doi: 10.1097/MD.0000000000036714.

引用本文的文献

1
Organoids to Remodel SARS-CoV-2 Research: Updates, Limitations and Perspectives.用于重塑新冠病毒研究的类器官:进展、局限性与展望
Aging Dis. 2023 Oct 1;14(5):1677-1699. doi: 10.14336/AD.2023.0209.
2
Integrated therapeutic plasma exchange and traditional Chinese medicine treatment in a patient with severe COVID-19: A case report.重症 COVID-19 患者采用综合治疗性血浆置换与中医药治疗:一例报告。
J Integr Med. 2022 Nov;20(6):575-580. doi: 10.1016/j.joim.2022.09.001. Epub 2022 Sep 3.

本文引用的文献

1
Isolation of 2019-nCoV from a Stool Specimen of a Laboratory-Confirmed Case of the Coronavirus Disease 2019 (COVID-19).从一名实验室确诊的2019冠状病毒病(COVID-19)病例的粪便样本中分离出2019新型冠状病毒。
China CDC Wkly. 2020 Feb 21;2(8):123-124.
2
COVID-19 vaccines: where we stand and challenges ahead.COVID-19 疫苗:我们的现状和未来的挑战。
Cell Death Differ. 2021 Feb;28(2):626-639. doi: 10.1038/s41418-020-00720-9. Epub 2021 Jan 21.
3
Dynamic monitoring of immune function indexes in COVID-19 patients.COVID-19 患者免疫功能指标的动态监测。
Aging (Albany NY). 2020 Dec 23;12(24):24596-24603. doi: 10.18632/aging.202362.
4
Excretion of SARS-CoV-2 through faecal specimens.粪便样本中 SARS-CoV-2 的排泄。
Emerg Microbes Infect. 2020 Dec;9(1):2501-2508. doi: 10.1080/22221751.2020.1844551.
5
COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms.COVID-19 相关的胃肠道和肝脏损伤:临床特征和潜在机制。
Signal Transduct Target Ther. 2020 Nov 2;5(1):256. doi: 10.1038/s41392-020-00373-7.
6
Vaccines against COVID-19.针对新型冠状病毒肺炎的疫苗。
Anaesth Crit Care Pain Med. 2020 Dec;39(6):703-705. doi: 10.1016/j.accpm.2020.10.006. Epub 2020 Oct 20.
7
Retention enema with traditional Chinese medicine for hepatic encephalopathy: A protocol for a systematic review and meta-analysis.中药保留灌肠治疗肝性脑病:一项系统评价与Meta分析方案
Medicine (Baltimore). 2020 Oct 2;99(40):e22517. doi: 10.1097/MD.0000000000022517.
8
Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building.高层建筑物中 SARS-CoV-2 粪便气溶胶传播的可能证据。
Ann Intern Med. 2020 Dec 15;173(12):974-980. doi: 10.7326/M20-0928. Epub 2020 Sep 1.
9
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.SARS-CoV-2 感染期间免疫反应概述:从过去中吸取的教训。
Front Immunol. 2020 Aug 7;11:1949. doi: 10.3389/fimmu.2020.01949. eCollection 2020.
10
Pros and cons of corticosteroid therapy for COVID-19 patients.COVID-19 患者使用皮质类固醇治疗的利弊。
Respir Physiol Neurobiol. 2020 Sep;280:103492. doi: 10.1016/j.resp.2020.103492. Epub 2020 Jul 10.